PointState Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-438,200
Closed -$11.6M 159
2017
Q2
$11.6M Buy
438,200
+161,700
+58% +$4.27M 0.13% 76
2017
Q1
$5.75M Buy
276,500
+101,500
+58% +$2.11M 0.06% 103
2016
Q4
$3.62M Sell
175,000
-150,000
-46% -$3.11M 0.05% 96
2016
Q3
$5.27M Buy
325,000
+75,000
+30% +$1.22M 0.05% 99
2016
Q2
$3.4M Buy
+250,000
New +$3.4M 0.07% 72